Target intelligence / Profile preview

Der1-like domain family, member 2 pseudogene (ENSG00000231923)

Target
ENSG00000231923
Molecular classification
Pseudogene
01

Overview

This entry refers to a **pseudogene**—a genomic DNA sequence similar to a functional gene (in this case, the Der1-like domain family, probably DERL2), but which lacks the ability to encode a functional protein[1][2][4][6]. Pseudogenes often arise by gene duplication or retrotransposition, but due to mutations (such as frameshifts or premature stop codons), they are not transcribed or translated into functional proteins[4]. While the protein-coding relatives of this family, such as Derlin-1 and Derlin-2, are involved in endoplasmic reticulum-associated degradation (ERAD) and protein quality control, **pseudogenes themselves do not participate directly in these functions**[1][4]. There are no established biological functions, disease associations, biomarkers, or drugs related to this specific pseudogene. Inclusion of this entry as a therapeutic target is **incorrect**, as pseudogenes are not considered druggable or functional targets in standard pharmacological or clinical contexts[2][4][6]. Summary: ENSG00000231923 (Der1-like domain family, member 2 pseudogene) is a nonfunctional sequence related to the derlin/DERL protein family and is not a therapeutic or biological target[1][2][4].

Other names
DERL2 pseudogeneDerlin 2 pseudogeneDerlin-like 2 pseudogene

Beyond the preview

Go deeper on Der1-like domain family, member 2 pseudogene (ENSG00000231923).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Der1-like domain family, member 2 pseudogene (ENSG00000231923).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call